A clinical trial of mupirocin in the eradication of methicillin-resistant Staphylococcus aureus nasal carriage in a digestive disease unit.
Dupeyron, C
A clinical trial of mupirocin in the eradication of methicillin-resistant Staphylococcus aureus nasal carriage in a digestive disease unit. [electronic resource] - The Journal of hospital infection Dec 2002 - 281-7 p. digital
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
0195-6701
10.1053/jhin.2002.1287 doi
Administration, Intranasal
Anti-Bacterial Agents--therapeutic use
Carrier State--drug therapy
Cross Infection--drug therapy
Drug Resistance, Bacterial
Feces--microbiology
Female
Hospital Units
Humans
Incidence
Infection Control--methods
Length of Stay--statistics & numerical data
Liver Diseases--complications
Male
Methicillin Resistance
Middle Aged
Mupirocin--therapeutic use
Nasopharynx--microbiology
Paris--epidemiology
Prevalence
Prospective Studies
Risk Factors
Staphylococcal Infections--drug therapy
Staphylococcus aureus--genetics
Treatment Outcome
A clinical trial of mupirocin in the eradication of methicillin-resistant Staphylococcus aureus nasal carriage in a digestive disease unit. [electronic resource] - The Journal of hospital infection Dec 2002 - 281-7 p. digital
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
0195-6701
10.1053/jhin.2002.1287 doi
Administration, Intranasal
Anti-Bacterial Agents--therapeutic use
Carrier State--drug therapy
Cross Infection--drug therapy
Drug Resistance, Bacterial
Feces--microbiology
Female
Hospital Units
Humans
Incidence
Infection Control--methods
Length of Stay--statistics & numerical data
Liver Diseases--complications
Male
Methicillin Resistance
Middle Aged
Mupirocin--therapeutic use
Nasopharynx--microbiology
Paris--epidemiology
Prevalence
Prospective Studies
Risk Factors
Staphylococcal Infections--drug therapy
Staphylococcus aureus--genetics
Treatment Outcome